Literature DB >> 8482281

Heterogeneity of Clostridium difficile isolates from infants.

A Collignon1, L Ticchi, C Depitre, J Gaudelus, M Delmée, G Corthier.   

Abstract

In order to improve our understanding of the role of Clostridium difficile in infants we characterised the strains isolated from this population. The production of toxin A and toxin B was studied. The toxin A, playing a major role in the disease, was searched for in faecal samples. The serogroup of the isolates was determined because some serogroups have been shown to be more pathogenic than others. Over a 9-month period, 102 faecal samples from 102 hospitalised infants (0-12 months) were analysed and 26% of the children were colonised with C. difficile. Fifteen isolates secreted neither toxin A nor B (62.5%). Nine isolates were toxigenic and secreted both toxins (37.5%). Of the eight toxigenic strains tested, six were from serogroup H and two serogroup K. Of the 13 nontoxigenic strains tested, 8 belonged to serogroup D, 2 to serogroup X, and 1 each to serogroup A, serogroup B and serogroup C. Three infants out of 102 studied had toxin A in their faeces. In summary, the infants can be colonised by (1) nontoxigenic strains, most of them from nonpathogenic serogroup D, without toxin A in the faeces; (2) toxigenic strains of virulent serogroups H and K, with or without toxin A in the faeces. Although some infants had diarrhoea, none needed a specific treatment for C. difficile. No specific C. difficile pathology could be retained and different mechanisms are advanced to explain this absence of pathogenicity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482281     DOI: 10.1007/bf01956743

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  28 in total

1.  Virulence of ten serogroups of Clostridium difficile in hamsters.

Authors:  M Delmée; V Avesani
Journal:  J Med Microbiol       Date:  1990-10       Impact factor: 2.472

2.  Medical implications of nosocomial infection with Clostridium difficile.

Authors:  S Eriksson; B Aronsson
Journal:  Scand J Infect Dis       Date:  1989

3.  Clostridium difficile in neonates: serogrouping and epidemiology.

Authors:  M Delmée; G Verellen; V Avesani; G Francois
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

4.  [Clostridium difficile in children and adolescents undergoing anticancer and antimicrobial chemotherapy. The possibility of nosocomial acquisition].

Authors:  A Collignon; C Chaumard; I Vallet-Collomb; N Delepine
Journal:  Pathol Biol (Paris)       Date:  1988-06

5.  Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis.

Authors:  S P Borriello; J M Ketley; T J Mitchell; F E Barclay; A R Welch; A B Price; J Stephen
Journal:  J Med Microbiol       Date:  1987-08       Impact factor: 2.472

6.  Modulation of cytotoxin production by Clostridium difficile in the intestinal tracts of gnotobiotic mice inoculated with various human intestinal bacteria.

Authors:  G Corthier; F Dubos; P Raibaud
Journal:  Appl Environ Microbiol       Date:  1985-01       Impact factor: 4.792

7.  Effect of various diets on toxin production by two strains of Clostridium difficile in gnotobiotic mice.

Authors:  S Mahe; G Corthier; F Dubos
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

8.  [Clostridium difficile and its cytotoxin in the stools of young hospitalized children. Influence of antibiotic treatment].

Authors:  A Collignon; J Cotte-Laffitte; A M Quero; J C Torlotin
Journal:  Pathol Biol (Paris)       Date:  1986-11

9.  Relationship between levels of Clostridium difficile toxin A and toxin B and cecal lesions in gnotobiotic mice.

Authors:  A Vernet; G Corthier; F Dubos-Ramaré; A L Parodi
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

10.  Serotyping of Clostridium difficile.

Authors:  S Toma; G Lesiak; M Magus; H L Lo; M Delmée
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

View more
  17 in total

1.  Toxin-producing Clostridium difficile strains as long-term gut colonizers in healthy infants.

Authors:  Ingegerd Adlerberth; Haihui Huang; Erika Lindberg; Nils Åberg; Bill Hesselmar; Robert Saalman; Carl Erik Nord; Agnes E Wold; Andrej Weintraub
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

2.  Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition.

Authors:  Clotilde Rousseau; Florence Levenez; Charlène Fouqueray; Joël Doré; Anne Collignon; Patricia Lepage
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

3.  Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces.

Authors:  J Dabard; C Bridonneau; C Phillipe; P Anglade; D Molle; M Nardi; M Ladiré; H Girardin; F Marcille; A Gomez; M Fons
Journal:  Appl Environ Microbiol       Date:  2001-09       Impact factor: 4.792

4.  IL-17-producing γδ T cells protect against Clostridium difficile infection.

Authors:  Yee-Shiuan Chen; Iuan-Bor Chen; Giang Pham; Tzu-Yu Shao; Hansraj Bangar; Sing Sing Way; David B Haslam
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

Review 5.  Control of Clostridium difficile Infection by Defined Microbial Communities.

Authors:  James Collins; Jennifer M Auchtung
Journal:  Microbiol Spectr       Date:  2017-09

6.  The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

Authors:  Justyna Bien; Vindhya Palagani; Przemyslaw Bozko
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

Review 7.  Clostridium difficile and the microbiota.

Authors:  Anna M Seekatz; Vincent B Young
Journal:  J Clin Invest       Date:  2014-07-18       Impact factor: 14.808

Review 8.  Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection.

Authors:  Caná L Ross; Jennifer K Spinler; Tor C Savidge
Journal:  Anaerobe       Date:  2016-05-12       Impact factor: 3.331

Review 9.  Emergence of fecal microbiota transplantation as an approach to repair disrupted microbial gut ecology.

Authors:  Alexander Khoruts; Alexa R Weingarden
Journal:  Immunol Lett       Date:  2014-08-10       Impact factor: 3.685

Review 10.  A clinical and epidemiological review of non-toxigenic Clostridium difficile.

Authors:  Mukil Natarajan; Seth T Walk; Vincent B Young; David M Aronoff
Journal:  Anaerobe       Date:  2013-05-29       Impact factor: 3.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.